Connection
David Albers to Cholangiocarcinoma
This is a "connection" page, showing publications David Albers has written about Cholangiocarcinoma.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.182 |
|
|
|
-
Virchow I, Treckmann JW, Prasnikar N, Linden G, Markus P, Schumacher B, Albers D, Herold T, Ting S, Schmidt H, Radunz S, Wiesweg M, Siveke J, Schuler M, Kasper S. A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO). Oncol Res Treat. 2023; 46(3):89-99.
Score: 0.182